Vasoactive intestinal peptide-mediated suppression of apoptosis in the ovary: Potential mechanisms of action and evidence of a conserved antiatretogenic role through evolution

Keyphrases

• Mechanism of Action 100%
• Apoptosis Inhibition 100%
• Vasoactive Intestinal Peptide 100%
• Follicle 45%
• Apoptosis 40%
• Preantral Follicles 25%
• Granulosa Cells 20%
• Insulin-like 15%
• Forskolin 15%
• Atresia 15%
• CAMP Signaling 15%
• Growth Factors 10%
• Cell Survival 10%
• Gonadotropins 10%
• Serum-free Conditions 10%
• DNA Cleavage 10%
• Follicular Cells 10%
• Tropics 5%
• Morphological Analysis 5%
• Inhibitory Effect 5%
• Genomic DNA (gDNA) 5%
• Cell Death 5%
• Health Status 5%
• Ovarian Follicle 5%
• Adenylyl Cyclase 5%
• Maximal Effect 5%
• Binding Protein 5%
• Bioactivity 5%
• Neuropeptides 5%
• Growth Factor Binding 5%
• Disorganization 5%
• Rat Ovary 5%
• Pyknosis 5%
• Nerve Fibers 5%
• Immature Rats 5%
• Protein Kinase A Pathway 5%
• Membrane Permeable 5%
• Immediate Action 5%
• Dose-dependent 5%

Veterinary Science and Veterinary Medicine

• Vasoactive Intestinal Peptide 100%
• Follicle 45%
• Rat 40%
• Granulosa Cell 25%
• Antral Follicle 25%
• Insulin-Like Growth Factor 1 10%
• Follicular Cell 10%
• Gonadotropin 10%
• In Vitro 10%
• Somatomedin 5%
• Neuropeptide 5%
• Ovarian Follicle 5%
• Nerve Fiber 5%
• Health Status 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Vasoactive Intestinal Polypeptide 100%
• Rat 40%
• Forskolin 15%
• Atresia 15%
• Gonadotropin 10%
• Somatomedin C 10%
• Equus 10%
• Cyclic AMP Dependent Protein Kinase 5%
• Neuropeptide 5%
• Adenylate Cyclase 5%
• Health Status 5%
• Genomic DNA 5%
• Somatomedin Binding Protein 3 5%
• Disorientation 5%